Evidence map›Paper›PMID 29362826›Full record

ArticleDiabetologia2018

Telomere length is reduced in 9- to 16-year-old girls exposed to gestational diabetes in utero.

Line Hjort, Regan Vryer, Louise G Grunnet, David Burgner, Sjurdur F Olsen, Richard Saffery, Allan Vaag

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Line HjortDepartment of Endocrinology (Diabetes and Metabolism), Section 7652, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. line.hjort@regionh.dk.ORCID 0000-0003-4673-4176
Regan VryerMurdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.
Louise G GrunnetDepartment of Endocrinology (Diabetes and Metabolism), Section 7652, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
David BurgnerMurdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.
Sjurdur F OlsenCentre for Fetal Programming, Statens Serum Institut, Copenhagen, Denmark.
Richard SafferyMurdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.
Allan VaagDepartment of Endocrinology (Diabetes and Metabolism), Section 7652, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
Copenhagen University Hospital · DKThe University of Melbourne · AUMurdoch Children's Research Institute · AUStatens Serum Institut · DKUniversity of Copenhagen · DK

Funding

NICHD NIH HHS HHSN275201000020C
6 · The paper itself

Abstract

aims/hypothesisShortened telomere length is a marker of cell damage and is associated with oxidative stress, chronic inflammation and metabolic disease. We hypothesised that the offspring of women with gestational diabetes mellitus (GDM) with increased risk of cardiovascular and metabolic diseases might exhibit shorter telomere length.

methodsWe investigated telomere length in 439 GDM and 469 control group offspring, aged between 9 and 16 years, recruited from the Danish National Birth Cohort. Relative telomere length was measured in peripheral blood DNA (n = 908) using a quantitative PCR approach. Multivariate regression analysis was used to investigate the association between mothers' GDM status and telomere length in the offspring.

resultsFemale offspring had longer telomeres than males. Offspring of mothers with GDM had significantly shorter telomere length than control offspring, but this difference was observed only in girls. There was a negative association between telomere length and GDM exposure among the female offspring (14% shorter telomeres, p = 0.003) following adjustment for the age of the offspring. Telomere length in female offspring was negatively associated with fasting insulin levels and HOMA-IR (p = 0.03). Maternal age, smoking, gestational age, birthweight and the offspring's anthropometric characteristics were not associated with telomere length (p ≥ 0.1). CONCLUSIONS/

interpretationThe 9- to 16-year-old girls of mothers with GDM had shorter telomeres than those from the control population. Further studies are needed to understand the extent to which shortened telomere length predicts and/or contributes to the increased risk of disease later in life among the offspring of women with GDM.

Indexed as

Prenatal Exposure Delayed EffectsTelomere ShorteningAdolescentAdultAnthropometryBirth WeightBlood GlucoseChildCohort StudiesDenmarkDiabetes, GestationalFemaleGestational AgeHumansInsulinK562 CellsBlood GlucoseInsulinDevelopmental programmingGestational diabetesInflammationOffspringOxidative stressTelomere lengthType 2 diabetes

Identifiers

PMID29362826
OpenAlexW2790677685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.